Adjuvant Therapy for Melanoma: Past, Current, and Future Developments.

Cancers (Basel) · 2020 · PMC7409361 · PMID 32708268

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The first interim analysis showed a trend towards OS benefit and an updated follow-up showed a maintained (albeit lesser) effect even four years after commencing study participation [ 50 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.